Drug intelligence / Profile preview

tobramycin + dexamethasone

Development stage
Approved
Lead developer
Alcon
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
Administration
Ophthalmic
01

Overview

Tobramycin + dexamethasone is a fixed-dose combination medication used primarily in ophthalmology. It combines tobramycin, an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding irreversibly to the 30S ribosomal subunit of susceptible bacteria, with dexamethasone, a potent synthetic glucocorticoid corticosteroid that suppresses inflammation by inhibiting phospholipase A2 and reducing the production of inflammatory mediators such as prostaglandins and leukotrienes. This combination is indicated for steroid-responsive inflammatory ocular conditions where there is either an existing superficial bacterial infection or a risk of such infection. The product is available as eye drops and ointment[1][3][4][5][6].

Brand names
TobradexTobrason
Other names
tobramycin and dexamethasone ophthalmic suspension
02

Targets

GR (Glucocorticoid receptor)Bacterial Ribosome

Beyond the preview

Go deeper on tobramycin + dexamethasone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on tobramycin + dexamethasone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call